Cascade Bio is an industrial biotechnology company focused on advancing enzyme-based processes to facilitate the transition from petrochemicals to biomanufacturing. Utilizing its innovative Body Armor for Enzymes™ technology, Cascade Bio enhances enzyme stability and performance, enabling cost-effective and scalable biocatalysis across various industries, including chemicals, flavors, fragrances, food ingredients, and pharmaceuticals. Headquartered in Denver, the company is dedicated to revolutionizing the chemical economy by promoting sustainable and efficient biomanufacturing solutions.
Cascade Bio LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Cascade Bio had 11 employees as of October 26, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Cascade Bio had 3,153 followers as of October 26, 2026. The number of followers increased by 12 (0.38%) week-over-week.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Sep 09, 2025 | Seed Round | $2.80M | ― |
| Investor Name | Funding Round |
|---|---|
| Range Ventures | Seed Round |
| 10vc | Seed Round |
| Stray Dog Capital | Seed Round |
| Endurance28 | Seed Round |
| 1Flourish | Seed Round |
| Amplify | Seed Round |
A snapshot of private companies similar to Cascade Bio, helping you discover and navigate related company profiles.



